Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder
| Status: | Recruiting |
|---|---|
| Conditions: | Other Indications, Overactive Bladder |
| Therapuetic Areas: | Gastroenterology, Other |
| Healthy: | No |
| Age Range: | 3 - 16 |
| Updated: | 4/25/2018 |
| Start Date: | May 2, 2011 |
| End Date: | June 12, 2020 |
| Contact: | Clinical Trials Registry Team |
| Email: | IR-CTRegistration@allergan.com |
| Phone: | 1-877-277-8566 |
A Two-part, Multicenter, Dose-titration Study Evaluating Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of Oxybutynin Chloride 10% Gel for Treatment of Detrusor Overactivity Associated Neurological Condition in Pediatric Patients
This study will evaluate the safety and efficacy of Oxybutynin Chloride 10% Topical Gel in
children 3 to less than 17 years old, who have overactive bladder due to a neurogenic
condition. Children will be treated with 0.75 g of gel/day for two weeks. Patients will then
return to the clinic for a potential dose titration. At this time their dose may be adjusted
up to 1g/day, down to 0.5g/day, or remain the same at 0.75g of gel/day depending on the
individual response and tolerability. The total treatment time is 14 weeks and total time on
the study is 16 weeks.
children 3 to less than 17 years old, who have overactive bladder due to a neurogenic
condition. Children will be treated with 0.75 g of gel/day for two weeks. Patients will then
return to the clinic for a potential dose titration. At this time their dose may be adjusted
up to 1g/day, down to 0.5g/day, or remain the same at 0.75g of gel/day depending on the
individual response and tolerability. The total treatment time is 14 weeks and total time on
the study is 16 weeks.
This study will use a two-part, multicenter, dose-titration study in pediatric patients with
a detrusor overactivity associated with a neurological condition
a detrusor overactivity associated with a neurological condition
Inclusion Criteria:
- 3 years to < 17 years
- Neurogenic bladder
- Neurological condition
- CIC
Exclusion Criteria:
- Have anatomical bladder abnormalities
- Sensitivity to anticholinergics
- Bladder augmentation
We found this trial at
16
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
University of Mississippi Medical Center The University of Mississippi Medical Center, located in Jackson, is...
Click here to add this to my saved trials
Cedars Sinai Med Ctr Cedars-Sinai is known for providing the highest quality patient care. Our...
Click here to add this to my saved trials
601 Children's Lane
Norfolk, Virginia 23507
Norfolk, Virginia 23507
(757) 668-7000
Children's Hospital of The King's Daughters Children
Click here to add this to my saved trials
Children's Hospital of Orange County For more than 45 years, CHOC Children’s has been steadfastly...
Click here to add this to my saved trials
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
Click here to add this to my saved trials
Albany Medical College Albany Medical Center is northeastern New York's only academic health sciences center...
Click here to add this to my saved trials
Click here to add this to my saved trials
Children's Hospital of Michigan Since 1886, the Children's Hospital of Michigan has been dedicated to...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
258 Calle San Jorge
San Juan, 00912
San Juan, 00912
Click here to add this to my saved trials